Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Equivalence of Glatiramer Acetate Generics With Branded Glatiramer Acetate in Efficacy and Cost for the Treatment of Multiple Sclerosis.

Literature DB >> 26457848

Equivalence of Glatiramer Acetate Generics With Branded Glatiramer Acetate in Efficacy and Cost for the Treatment of Multiple Sclerosis.

Dennis Bourdette¹, Daniel Hartung².

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2015 PMID： 26457848 DOI： 10.1001/jamaneurol.2015.2605

Source DB: PubMed Journal: JAMA Neurol ISSN： 2168-6149 Impact factor: 18.302

Keyword Cloud
Cited

× No keyword cloud information.

4 in total

Review 1. Economics and Cost-Effectiveness of Multiple Sclerosis Therapies in the USA.

Authors: Daniel M Hartung
Journal: Neurotherapeutics Date: 2017-10 Impact factor: 7.620

2. Multiple sclerosis. Generic glatiramer acetate--a step toward cheaper MS drugs?

Authors: Per Soelberg Sørensen
Journal: Nat Rev Neurol Date: 2015-12-04 Impact factor: 42.937

Review 3. Development of Glatopa® (Glatiramer Acetate): The First FDA-Approved Generic Disease-Modifying Therapy for Relapsing Forms of Multiple Sclerosis.

Authors: Christine Bell; James Anderson; Tanmoy Ganguly; James Prescott; Ishan Capila; Jonathan C Lansing; Richard Sachleben; Mani Iyer; Ian Fier; James Roach; Kristina Storey; Paul Miller; Steven Hall; Daniel Kantor; Benjamin M Greenberg; Kavita Nair; Joseph Glajch
Journal: J Pharm Pract Date: 2017-08-29

Review 4. A Comprehensive Review on Copemyl^®.

Authors: Pietro Annovazzi; Antonio Bertolotto; Vincenzo Brescia Morra; Claudio Gasperini; Enrico Montanari; Pierluigi Navarra; Francesco Patti; Maria Pia Sormani; Angelo Ghezzi
Journal: Neurol Ther Date: 2017-07-31